Brief: Revision Skincare Announces Partnership With RVL Pharmaceuticals
30/08/2022 12:04
Aug 30 (Reuters) - RVL Pharmaceuticals PLC RVLP.O :
* REVISION SKINCARE® ANNOUNCES STRATEGIC PARTNERSHIP WITH
RVL
PHARMACEUTICALS PLC
Source text for Eikon: ID:nGNX9MfyS7
Further company coverage: RVLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius